`
`RFB002
`0.5MG/0.05ML Liquid in (pre-filled) syringe
`
`Author(s):
`
`Valid date:
`
`Date of approval
`
`Number of pages:
`
`44
`
`Property of Novartis
`Confidential
`May not be used, divulged, published or otherwise disclosed
`without the consent of Novartis
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`Novartis Exhibit 2064.001
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`Novartis Exhibit 2064.002
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`Thb document (090095$9$!048676 in dccbilM TtDI ... CH} has b$$n di,1italiy signed with <Uxternai t.ignatur<Us using Entrust PK!.
`Ccmp~eN~d ( 1 Qf t s~gnatunss}
`Approved for \JSe ny····••■:,, 8;;,s;Ji at Wed, Jul 18, 2012 1$.17::37 CEST
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`Novartis Exhibit 2064.003
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`Novartis Exhibit 2064.004
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`Novartis Exhibit 2064.005
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`Thb document (090095$9$!048676 in dccbilM TtDI ... CH} has b$$n di,1italiy signed with <Uxternai t.ignatur<Us using Entrust PK!.
`Ccmp~eN~d ( 1 Qf t s~gnatunss}
`Approved for \JSe ny····••■:,, 8;;,s;Ji at Wed, Jul 18, 2012 1$.17::37 CEST
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`Novartis Exhibit 2064.006
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`Novartis Exhibit 2064.007
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`Thb document (090095$9$!048676 in dccbilM TtDI ... CH} has b$$n di,1italiy signed with <Uxternai t.ignatur<Us using Entrust PK!.
`Ccmp~eN~d ( 1 Qf t s~cnatunss}
`Approved for \JSe ny· · · · · ·" 8;;,s;Ji at Wed, Jul 18, 2012 1$.17::37 CEST
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`Novartis Exhibit 2064.008
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`Thb document (090095$9$!048676 in dccbilM TtDI ... CH} has b$$n di,1italiy signed with <Uxternai t.ignatur<Us using Entrust PK!.
`Ccmp~eN~d ( 1 Qf t s~gnatunss}
`Approved for \JSe ny -■-■■-:,, 8;;,s;Ji at Wed, Jul 18, 2012 1$.17::37 CEST
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`Novartis Exhibit 2064.009
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`Novartis Exhibit 2064.0010
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`Thb document (090095$9$!048676 in dccbilM TtDI ... CH} has b$$n di,1italiy signed with <Uxternai t.ignatur<Us using Entrust PK!.
`Ccmp~eN~d ( 1 Qf t s~gnatunss}
`Approved for \JSe ny ■■■■■■" 8;;,s;Ji at Wed, Jul 18, 2012 1$.17::37 CEST
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`Novartis Exhibit 2064 .0011
`Regeneron v. Novartis, IPR2021-008 16
`
`
`
`Thb document (090095$9$!048676 in dccbilM TtDI ... CH} has b$$n di,1italiy signed with <Uxternai t.ignatur<Us using Entrust PK!.
`Ccmp~eN~d ( 1 Qf t s~gnatunss}
`Approved for \JSe ny -■-■■-:,, 8;;,s;Ji at Wed, Jul 18, 2012 1$.17::37 CEST
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`Novartis Exhibit 2064 .0012
`Regeneron v. Novartis, IPR2021-008 16
`
`
`
`Thb document (090095$9$!048676 in dccbilM TtDI ... CH} has b$$n di,1italiy signed with <Uxternai t.ignatur<Us using Entrust PK!.
`Ccmp~eN~d ( 1 Qf t s~gnatunss}
`Approved for \JSe ny ■■■■■■" 8;;,s;Ji at Wed, Jul 18, 2012 1$.17::37 CEST
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`Novartis Exhibit 2064.001 3
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`Novartis Exhibit 2064.0014
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`Thb document (090095$9$!048676 in dccbilM TtDI ... CH} has b$$n di,1italiy signed with <Uxternai t.ignatur<Us using Entrust PK!.
`Ccmp~eN~d ( 1 Qf t s~gnatunss}
`Approved fon,se ny
`
`:,, 8;;,s;Ji at Wed, Jul 18, 2012 1$.17::37 CEST
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`Novartis Exhibit 2064 .001 5
`Regeneron v. Novartis, IPR2021-008 16
`
`
`
`Thb document (090095$9$!048676 in dccbilM TtDI ... CH} has b$$n di,1italiy signed with <Uxternai t.ignatur<Us using Entrust PK!.
`Ccmp~eN~d ( 1 Qf t s~gnatunss}
`Approved for \JSe ny -■-■■■ :,, 8;;,s;Ji at Wed, Jul 18, 2012 1$.17::37 CEST
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`Novartis Exhibit 2064.001 6
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`Novartis Exhibit 2064.0017
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`Thb document (090095$9$!048676 in dccbilM TtDI ... CH} has b$$n di,1italiy signed with <Uxternai t.ignatur<Us using Entrust PK!.
`Ccmp~eN~d ( 1 Qf t s~gnatunss}
`Approved for \JSe ny· • · • • •:,, 8;;,s;Ji at Wed, Jul 18, 2012 1$.17::37 CEST
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`Novartis Exhibit 2064.001 8
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`Novartis Exhibit 2064.001 9
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`Thb document (090095$9$!048676 in dccbilM TtDI ... CH} has b$$n di,1italiy signed with <Uxternai t.ignatur<Us using Entrust PK!.
`Ccmp~eN~d ( 1 Qf t s~gnatunss}
`Approved for \JSe ny · • · • • •:,, 8;;,s;Ji at Wed, Jul 18, 2012 1$.17::37 CEST
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`Novartis Exhibit 2064.0020
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`Thb document (090095$9$!048676 in dccbilM TtDI ... CH} has b$$n di,1italiy signed with <Uxternai t.ignatur<Us using Entrust PK!.
`Ccmp~eN~d ( 1 Qf t s~gnatunss}
`Approved for \JSe ny -■-■■■ :,, 8;;,s;Ji at Wed, Jul 18, 2012 1$.17::37 CEST
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`Novartis Exhibit 2064 .002 1
`Regeneron v. Novartis, IPR2021-008 16
`
`
`
`Thb document (090095$9$!048676 in dccbilM TtDI ... CH} has b$$n di,1italiy signed with <Uxternai t.ignatur<Us using Entrust PK!.
`Ccmp~eN~d ( 1 Qf t s~gnatunss}
`Approved fon,se ny
`
`:,, 8;;,s;Ji at Wed, Jul 18, 2012 1$.17::37 CEST
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`Novartis Exhibit 2064 .0022
`Regeneron v. Novartis, IPR2021-008 16
`
`
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`Novartis Exhibit 2064.0023
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`Thb document (090095$9$!048676 in dccbilM TtDI ... CH} has b$$n di,1italiy signed with <Uxternai t.ignatur<Us using Entrust PK!.
`Ccmp~eN~d ( 1 Qf t s~cnatt:r~s•
`Approved fon,se ny
`
`:,, 8;;,s;Ji at Wed, Jul 18, 2012 1$.17::37 CEST
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`Novartis Exhibit 2064.0024
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`Novartis Exhibit 2064.0025
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`Thb document (090095$9$!048676 in dccbilM TtDI ... CH} has b$$n di,1italiy signed with <Uxternai t.ignatur<Us using Entrust PK!.
`Ccmp~eN~d ( 1 Qf t s~gnatunss}
`Approved for \JSe ny·•■-■■■:,, 8;;,s;Ji at Wed, Jul 18, 2012 1$.17::37 CEST
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`Novartis Exhibit 2064.0026
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`Novartis Exhibit 2064.0027
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`Novartis Exhibit 2064.0028
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`Novartis Exhibit 2064.0029
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`Thb document (090095$9$!048676 in dccbilM TtDI ... CH} has b$$n di,1italiy signed with <Uxternai t.ignatur<Us using Entrust PK!.
`Ccmp~eN~d ( 1 Qf t s~gnatunss}
`Approved fon,se ny
`
`:,, 8;;,s;Ji at Wed, Jul 18, 2012 1$.17::37 CEST
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`Novartis Exhibit 2064.0030
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`Thb document (090095$9$!048676 in dccbilM TtDI ... CH} has b$$n di,1italiy signed with <Uxternai t.ignatur<Us using Entrust PK!.
`Ccmp~eN~d ( 1 Qf t s~gnatunss}
`Approved for \JSe ny -■-■■-:,, 8;;,s;Ji at Wed, Jul 18, 2012 1$.17::37 CEST
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`Novartis Exhibit 2064.0031
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`Thb document (090095$9$!048676 in dccbilM TtDI ... CH} has b$$n di,1italiy signed with <Uxternai t.ignatur<Us using Entrust PK!.
`Ccmp~eN~d ( 1 Qf t s~gnatunss}
`Approved for \JSe ny · • · • • •:,, 8;;,s;Ji at Wed, Jul 18, 2012 1$.17::37 CEST
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`Novartis Exhibit 2064.0032
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`Novartis Exhibit 2064.0033
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`Thb document (090095$9$!048676 in dccbilM TtDI ... CH} has b$$n di,1italiy signed with <Uxternai t.ignatur<Us using Entrust PK!.
`Ccmp~eN~d ( 1 Qf t s~gnatunss}
`Approved for \JSe ny -■-■■■" 8;;,s;Ji at Wed, Jul 18, 2012 1$.17::37 CEST
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`Novartis Exhibit 2064.0034
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`Thb document (090095$9$!048676 in dccbilM TtDI ... CH} has b$$n di,1italiy signed with <Uxternai t.ignatur<Us using Entrust PK!.
`Ccmp~eN~d ( 1 Qf t s~gnatunss}
`Approved for \JSe ny · • · • • •" 8;;,s;Ji at Wed, Jul 18, 2012 1$.17::37 CEST
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`Novartis Exhibit 2064.0035
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`Thb document (090095$9$!048676 in dccbilM TtDI ... CH} has b$$n di,1italiy signed with <Uxternai t.ignatur<Us using Entrust PK!.
`Ccmp~eN~d ( 1 Qf t s~gnatunss}
`Approved fon,se ny
`
`"8;;,s;Ji at Wed, Jul 18, 2012 1$.17::37 CEST
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`Novartis Exhibit 2064.0036
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`Novartis Exhibit 2064.0037
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`Novartis Exhibit 2064.0038
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`Novartis Exhibit 2064.0039
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`Novartis Exhibit 2064.0040
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`Novartis Exhibit 2064.0041
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`Novartis Exhibit 2064.0042
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`Novartis Exhibit 2064.0043
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`Thb document (090095$9$!048676 in dccbilM TtDI ... CH} has b$$n di,1italiy signed with <Uxternai t.ignatur<Us using Entrust PK!.
`Ccmp~eN~d ( 1 Qf t s~gnatunss}
`Approved for \JSe ny·· · · · · ·" 8;;,s;Ji at Wed, Jul 18, 2012 1$.17::37 CEST
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`Novartis Exhibit 2064.0044
`Regeneron v. Novartis, IPR2021-00816
`
`